ATE204019T1 - Steigerung der transplantattoleranz durch schwein cytokine - Google Patents

Steigerung der transplantattoleranz durch schwein cytokine

Info

Publication number
ATE204019T1
ATE204019T1 AT93925071T AT93925071T ATE204019T1 AT E204019 T1 ATE204019 T1 AT E204019T1 AT 93925071 T AT93925071 T AT 93925071T AT 93925071 T AT93925071 T AT 93925071T AT E204019 T1 ATE204019 T1 AT E204019T1
Authority
AT
Austria
Prior art keywords
porcine
bone marrow
marrow cells
increase
cytokine
Prior art date
Application number
AT93925071T
Other languages
English (en)
Inventor
Paul D Ponath
Margaret D Rosa
Rodney L Monroy
Bernice Z Schacter
Robert J Hawley
Original Assignee
Biotransplant Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotransplant Inc filed Critical Biotransplant Inc
Application granted granted Critical
Publication of ATE204019T1 publication Critical patent/ATE204019T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT93925071T 1992-10-27 1993-10-26 Steigerung der transplantattoleranz durch schwein cytokine ATE204019T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96718892A 1992-10-27 1992-10-27
US08/133,979 US5589582A (en) 1992-10-27 1993-10-08 Polynucleotides en coding porcine cytokines
PCT/US1993/010295 WO1994009803A1 (en) 1992-10-27 1993-10-26 Enhancement of xenograft tolerance and porcine cytokines therefor

Publications (1)

Publication Number Publication Date
ATE204019T1 true ATE204019T1 (de) 2001-08-15

Family

ID=26831859

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93925071T ATE204019T1 (de) 1992-10-27 1993-10-26 Steigerung der transplantattoleranz durch schwein cytokine

Country Status (8)

Country Link
US (3) US5589582A (de)
EP (1) EP0669829B1 (de)
JP (1) JP3784063B2 (de)
AT (1) ATE204019T1 (de)
AU (2) AU5452194A (de)
CA (1) CA2147989C (de)
DE (1) DE69330566T2 (de)
WO (1) WO1994009803A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5523226A (en) * 1993-05-14 1996-06-04 Biotechnology Research And Development Corp. Transgenic swine compositions and methods
GB9515839D0 (en) * 1995-08-02 1995-10-04 Q One Biotech Ltd Feline stem cell factor
US6011197A (en) 1997-03-06 2000-01-04 Infigen, Inc. Method of cloning bovines using reprogrammed non-embryonic bovine cells
US6428782B1 (en) 1997-05-23 2002-08-06 Hadasit Medical Research Services And Development Ltd. Non-myeloablative tolerogenic treatment
US6447767B1 (en) 1997-05-23 2002-09-10 Hadasit Medical Research Services And Development Ltd. Non-myeloablative tolerogenic treatment
WO1999009163A1 (en) * 1997-08-13 1999-02-25 Biotransplant, Inc. Porcine stem cell factor varients and recombinant cells expressing such polypeptides
WO1999009141A1 (en) * 1997-08-14 1999-02-25 Biotransplant, Inc. Porcine totipotent cells and method for long-term culture
US6248587B1 (en) * 1997-11-26 2001-06-19 University Of Southern Cailfornia Method for promoting mesenchymal stem and lineage-specific cell proliferation
US6703209B1 (en) * 1998-08-13 2004-03-09 Biotransplant, Inc. Porcine totipotent cells and method for long-term culture
US6700037B2 (en) 1998-11-24 2004-03-02 Infigen, Inc. Method of cloning porcine animals
US6258998B1 (en) 1998-11-24 2001-07-10 Infigen, Inc. Method of cloning porcine animals
US6538028B1 (en) 2000-02-01 2003-03-25 Vanderbilt University Method for inhibiting complement activation
CA2427996A1 (en) * 2000-11-22 2002-06-06 Geron Corporation Tolerizing allografts of pluripotent stem cells
WO2002083838A2 (en) * 2001-03-28 2002-10-24 Nextran, Inc. Elimination of endogenous porcine retrovirus
US20020152490A1 (en) * 2001-04-12 2002-10-17 Philip Lake Tolerance-inducing thy-marrow composite tissue construct and organ
AU2002363322A1 (en) * 2001-10-26 2003-05-19 Large Scale Biology Corporation Endothelial cell derived hemotopoietic growth factor
EP3170890A1 (de) 2002-08-21 2017-05-24 Revivicor, Inc. Schweine ohne expression von funktionaler alpha-1,3-galactosyltransferase
US7560538B2 (en) 2003-11-05 2009-07-14 University Of Pittsburgh Porcine isogloboside 3 synthase protein, cDNA, genomic organization, and regulatory region
CA2559720A1 (en) 2004-03-17 2005-09-29 Revivicor, Inc. Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase
US7359066B2 (en) 2004-09-27 2008-04-15 Idc, Llc Electro-optical measurement of hysteresis in interferometric modulators
US7489849B2 (en) * 2004-11-03 2009-02-10 Adc Telecommunications, Inc. Fiber drop terminal
ES2657480T3 (es) 2006-08-11 2018-03-05 Life Sciences Research Partners Vzw Péptidos inmunogénicos y su uso en trastornos inmunitarios
US20100330088A1 (en) * 2008-02-14 2010-12-30 Jean-Marie Saint-Remy Strategies to prevent and/or treat immunie responses to soluble allofactors
AU2008350785B2 (en) * 2008-02-14 2013-10-03 Katholieke Universiteit Leuven Immunogenic peptides and their use in transplantation
ES2650236T3 (es) 2008-02-14 2018-01-17 Life Sciences Research Partners Vzw Linfocitos T CD4+ con propiedades citolíticas
EP2623125A1 (de) 2008-02-14 2013-08-07 Life Sciences Research Partners VZW Beseitigung von Immunantworten an virale Vektoren
EP2719396B1 (de) 2008-02-14 2017-06-21 Life Sciences Research Partners VZW Auf intrazelluläre Pathogene abzielende Immuntherapie
WO2009101205A2 (en) * 2008-02-14 2009-08-20 Life Sciences Research Partners Vzw Immunogenic control of tumours and tumour cells
US9420770B2 (en) 2009-12-01 2016-08-23 Indiana University Research & Technology Corporation Methods of modulating thrombocytopenia and modified transgenic pigs
HUE055070T2 (hu) 2010-11-25 2021-10-28 Imnate Sarl Immunogén peptidek fertõzõ betegségek, autoimmun betegségek, allofaktorokra adott immunválaszok, allergiás betegségek, tumorok, graftkilökõdés, és génterápiához vagy génvakcinációhoz alkalmazott vírusvektorokkal szembeni immunválaszok megelõzésében és/vagy kezelésében történõ alkalmazásra
WO2012096960A2 (en) * 2011-01-10 2012-07-19 The Regents Of The University Of Michigan Stem cell factor inhibitor
GB201201511D0 (en) 2012-01-30 2012-03-14 Univ Leuven Kath Modified epitopes for boosting CD4+ T-cell responses
GB201309469D0 (en) 2013-05-28 2013-07-10 Imcyse Sa Detection of CD4+ T lymphocytes
GB201418433D0 (en) 2014-10-17 2014-12-03 Imcyse Sa Novel immunogenic peptides
US10729791B2 (en) 2015-05-18 2020-08-04 Imcyse Sa Animal models for evaluating pharmaceutical compounds
AU2016328582B2 (en) 2015-09-25 2022-11-24 Imcyse Sa Improved methods and compounds for eliminating immune responses to therapeutic agents
US11485768B2 (en) 2016-04-19 2022-11-01 Imcyse Sa Immunogenic CD1d binding peptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106733A (en) * 1987-06-25 1992-04-21 Immunex Corporation Bovine granulocyte-macrophage colony stimulating factor
DE69028514T2 (de) * 1989-01-10 1997-02-20 Amrad Corp Ltd Leukämiehemmender faktor aus vieharten und seine verwendung zur verbesserung der implantation und der entwicklung von embryonalen zellen
DK0598029T3 (da) * 1991-08-07 2002-05-27 W French Anderson Retrovirale vektorer indeholdende interne ribosome indgangssteder

Also Published As

Publication number Publication date
CA2147989C (en) 2002-10-22
DE69330566D1 (de) 2001-09-13
JPH08502650A (ja) 1996-03-26
AU703371B2 (en) 1999-03-25
EP0669829B1 (de) 2001-08-08
WO1994009803A1 (en) 1994-05-11
US5589582A (en) 1996-12-31
AU5035998A (en) 1998-03-19
US5863528A (en) 1999-01-26
CA2147989A1 (en) 1994-05-11
JP3784063B2 (ja) 2006-06-07
AU5452194A (en) 1994-05-24
EP0669829A1 (de) 1995-09-06
EP0669829A4 (de) 1997-05-07
DE69330566T2 (de) 2002-06-27
US5858963A (en) 1999-01-12

Similar Documents

Publication Publication Date Title
ATE204019T1 (de) Steigerung der transplantattoleranz durch schwein cytokine
ATE452190T1 (de) Verfahren zur isolierung und reinigung von g-csf
ATE297980T1 (de) Verfahren zur klonierung von schweinen
NZ237666A (en) Hiv envelope (env) polypeptides, antibodies and compositions for treating aids
ATE199096T1 (de) Il-11 aus säugetier
DK0661989T3 (da) Proteinsammensætninger med vedvarende frigivelse
ATE321774T1 (de) An aminosaeure angereicherte speicherproteine, insbesondere an lysin angereicherte mais-gamma- zeine, und diese exprimierende pflanzen
DE3485759D1 (de) Reinigung von rekombinanten interleukin-2.
ATE279441T1 (de) Verfahren zur herstellung von genetisch veränderten lymphozyten vorläuferzellen von wirbeltieren und deren gebrauch zur produktion von heterologen bindeproteinen
DK12990A (da) Human granulocyt-makrofag-kolonistimulerende faktor og muteiner heraf
MX9304209A (es) Composicion y metodo de tratamiento de hepatitis b.
ATE226087T1 (de) Verwendung von neuen zelltod inducierenden mitteln im synergismus mit interferon
DK0687300T3 (da) LO-CD2a-antistof og anvendelser deraf til inhibering af T-celle-aktivering og -proliferation
DE69527640D1 (de) Zusammensetzungen die gemischte transferrine als wirkstoff für induktion von immunotoleranz gegen antigen enthalten
ES2142840T3 (es) Proteina que se une al interferon alfa/beta, su preparacion y las composiciones farmaceuticas que la contienen.
ATE110770T1 (de) Proliferation von cd4-lymfocyten.
Hawley et al. Porcine cytokines
DE60026666D1 (de) Induktion von antigen-spezifischen T-Zellen durch Interferon
ATE33842T1 (de) Immuninterferon und verfahren zu seiner reinigung.
Hawley et al. Polynucleotides en coding porcine cytokines
ATE253378T1 (de) Xenogene transplantation

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee